Cargando…
Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model
Primary ovarian insufficiency (POI), a condition in which there is a loss of ovarian function before the age of 40 years, leads to amenorrhea and infertility. In our previously published studies, we demonstrated recovery of POI, correction of serum sex hormone levels, increase in the granulosa cell...
Autores principales: | Park, Hang-Soo, Chugh, Rishi Man, Elsharoud, Amro, Ulin, Mara, Esfandyari, Sahar, Aboalsoud, Alshimaa, Bakir, Lale, Al-Hendy, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894598/ https://www.ncbi.nlm.nih.gov/pubmed/33593078 http://dx.doi.org/10.1177/0963689720988502 |
Ejemplares similares
-
Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10
por: Chugh, Rishi Man, et al.
Publicado: (2021) -
Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2
por: Chugh, Rishi Man, et al.
Publicado: (2021) -
Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency
por: Ulin, Mara, et al.
Publicado: (2021) -
Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model
por: Park, Hang-soo, et al.
Publicado: (2021) -
Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage
por: Park, Hang-soo, et al.
Publicado: (2023)